Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) was up 16.4% during trading on Friday . The stock traded as high as GBX 32 ($0.42) and last traded at GBX 32 ($0.42). Approximately 92,950 shares changed hands during trading, a decline of 44% from the average daily volume of 167,168 shares. The stock had previously closed at GBX 27.50 ($0.36).
Beximco Pharmaceuticals Price Performance
The company has a 50 day moving average price of GBX 27.15 and a 200 day moving average price of GBX 34.52. The company has a current ratio of 1.80, a quick ratio of 0.37 and a debt-to-equity ratio of 14.73. The company has a market capitalization of £142.76 million, a P/E ratio of 343.75 and a beta of 0.61.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
Further Reading
- Five stocks we like better than Beximco Pharmaceuticals
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Oil Prices Fall, Sector Pulls Back: Time to Buy this Stock?
- Investing in the High PE Growth Stocks
- AI Boom Fuels Demand for Dominion Energy Stock
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Cathie Wood Cuts Robinhood Holdings—Follow Her Lead or Stay Put?
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
